Fix J, Vielot NA, Lund JL, Weber DJ, et al. Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States. Vaccine 2022 Nov 14. pii: S0264-410X(22)01347.
PMID: 36396511